Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacy in Australia: are we research ready?

The International journal of pharmacy practice·2026
Same author

Global trends in clozapine utilisation between 2014 and 2024: a longitudinal epidemiological study with data from 75 countries.

The Lancet regional health. Europe·2026
Same author

Exploring Law Enforcement Officers' Experiences with Athletic Trainers and Work-Related Injury.

International journal of environmental research and public health·2025
Same author

A phenomenological study of women with breast cancer-related lymphedema using the healthcare system.

The British journal of occupational therapy·2025
Same author

Scoping Review of Co-Design in Mental Health Research: Essential Elements and Recommendations.

OTJR : occupation, participation and health·2025
Same author

Comprehensive Breast Cancer-Related Lymphedema Management Programs Addressing both Psychosocial and Physical Needs: A Scoping Review.

The open journal of occupational therapy·2025

Related Experiment Videos

Explicit versus implicit review to explore combination antipsychotic prescribing.

Amanda Wheeler1

  • 1Clinical Research and Resource Centre, Mental Health and Addiction Services, Waitakere Hospital, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. wheeler@waitematadhb.govt.nz

Journal of Evaluation in Clinical Practice
|August 14, 2009
PubMed
Summary
This summary is machine-generated.

Explicit audits overestimate antipsychotic polytherapy deviations in schizophrenia care. Structured implicit review offers a more accurate quality assessment for complex patients, identifying those needing targeted interventions.

Related Experiment Videos

Area of Science:

  • Psychiatry
  • Clinical Pharmacy
  • Health Services Research

Background:

  • Antipsychotic polyprescribing is common in schizophrenia treatment.
  • Explicit audit criteria may overestimate deviations from best practice.
  • Accurate quality assessment is crucial for patient outcomes.

Purpose of the Study:

  • To determine the true rate of antipsychotic polytherapy deviating from best practice in schizophrenia treatment.
  • To assess the appropriateness of explicit criteria for identifying at-risk patients and evaluating care quality.

Main Methods:

  • A large-scale explicit audit of antipsychotic prescribing was conducted in Auckland, New Zealand.
  • Patients on polytherapy were followed up, and medication summaries were prepared.
  • Structured implicit review by independent raters was used to assess the justification of polytherapy.

Main Results:

  • The initial rate of antipsychotic polytherapy was 10.6%, reducing to 3.5% after excluding short-term cases and incorporating clinical context.
  • Polytherapy was rated 'well-justified' in 32.7% and 'lacked justification' in 46.9% of cases.
  • Structured implicit review provided a more nuanced assessment of polytherapy quality compared to explicit criteria.

Conclusions:

  • Explicit audit criteria serve as a useful baseline but overestimate deviations from best practice in antipsychotic prescribing.
  • Structured treatment review is valuable for identifying complex patients at risk of poor outcomes.
  • Implicit review enhances the accuracy of quality of care assessments in routine practice.